Terms: = Prostate cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29
78 results:
1. Causal relationship between Alzheimer's disease and prostate cancer: a bidirectional Mendelian randomization analysis.
Li R; Peng L; Deng D; Li G; Wu S
Front Endocrinol (Lausanne); 2024; 15():1354528. PubMed ID: 38544686
[TBL] [Abstract] [Full Text] [Related]
2. Algorithms for classification of sequences and segmentation of prostate gland: an external validation study.
Yin X; Wang K; Wang L; Yang Z; Zhang Y; Wu P; Zhao C; Zhang J
Abdom Radiol (NY); 2024 Apr; 49(4):1275-1287. PubMed ID: 38436698
[TBL] [Abstract] [Full Text] [Related]
3. A machine learning radiomics model based on bpMRI to predict bone metastasis in newly diagnosed prostate cancer patients.
Xinyang S; Shuang Z; Tianci S; Xiangyu H; Yangyang W; Mengying D; Jingran Z; Feng Y
Magn Reson Imaging; 2024 Apr; 107():15-23. PubMed ID: 38181835
[TBL] [Abstract] [Full Text] [Related]
4. Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for prostate cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial.
Neylon J; Ma TM; Savjani R; Low DA; Steinberg ML; Lamb JM; Nickols NG; Kishan AU; Cao M
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1181-1191. PubMed ID: 38160916
[TBL] [Abstract] [Full Text] [Related]
5. A Meta-Analysis of Randomized Clinical Trials Assessing the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant prostate cancer.
Alameddine Z; Niazi MRK; Rajavel A; Behgal J; Keesari PR; Araji G; Mustafa A; Wei C; Jahangir A; Terjanian TO
Curr Oncol; 2023 Oct; 30(10):9262-9275. PubMed ID: 37887569
[TBL] [Abstract] [Full Text] [Related]
6. Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant prostate cancer via Macrophage Phagocytosis.
Chaudagar K; Hieromnimon HM; Kelley A; Labadie B; Shafran J; Rameshbabu S; Drovetsky C; Bynoe K; Solanki A; Markiewicz E; Fan X; Loda M; Patnaik A
Clin Cancer Res; 2023 Dec; 29(23):4930-4940. PubMed ID: 37721526
[TBL] [Abstract] [Full Text] [Related]
7. Transformation of proteins into reproductive DNA templates for sensitive quantification of PSA.
Li Z; Fu J; Wang L; Zhou Y; Li J; He S
Talanta; 2024 Jan; 267():125206. PubMed ID: 37716239
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic concordance between traditional and digital workflows. A study on 1427 prostate biopsies.
Torresani E; Gentilini MA; Grassi S; Cima L; Pedrolli I; Cai T; Puglisi M; Vattovani V; Guadin B; Brunelli M; Doglioni C; Barbareschi M
Pathologica; 2023 Aug; 115(4):221-226. PubMed ID: 37711038
[TBL] [Abstract] [Full Text] [Related]
9. Application of Dynamic Enhanced Magnetic Resonance Imaging Texture Analysis Combined with ADCs in Predicting Pelvic Lymph Metastasis of prostate cancer.
Yao L; Ding J; Li X; Yang J; Chen Z; Jia C; Duan Q
Arch Esp Urol; 2023 Aug; 76(6):383-388. PubMed ID: 37681328
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.
Yang C; Liu Z; Fang Y; Cao X; Xu G; Wang Z; Hu Z; Wang S; Wu X
J Transl Med; 2023 Jul; 21(1):465. PubMed ID: 37438820
[TBL] [Abstract] [Full Text] [Related]
11. Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non-Indigenous men in a universal health care system.
Kiciak A; Clark W; Uhlich M; Letendre A; Littlechild R; Lightning P; Vasquez C; Singh R; Broomfield S; Martin AM; Huang G; Fairey A; Kolinsky M; Wallis CJD; Fung C; Hyndman E; Yip S; Bismar TA; Lewis J; Ghosh S; Kinnaird A
Cancer; 2023 Sep; 129(18):2864-2870. PubMed ID: 37424308
[TBL] [Abstract] [Full Text] [Related]
12. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of thresholding methods for the quantification of [
Kim M; Seifert R; Fragemann J; Kersting D; Murray J; Jonske F; Pomykala KL; Egger J; Fendler WP; Herrmann K; Kleesiek J
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2196-2209. PubMed ID: 36859618
[TBL] [Abstract] [Full Text] [Related]
14. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract] [Full Text] [Related]
15. Early-onset malignant solid tumours in young adult South Africans - an audit based on histopathological records of patients seen at the three academic hospitals in Johannesburg.
Ugare UG; Bombil I; Luvhengo TE
S Afr J Surg; 2022 Jun; 60(2):134-140. PubMed ID: 35851369
[TBL] [Abstract] [Full Text] [Related]
16. Contrast-Enhanced Ultrasound-Magnetic Resonance Imaging Radiomics Based Model for Predicting the Biochemical Recurrence of prostate cancer: A Feasibility Study.
Wang Y; Feng G; Wang J; An P; Duan P; Hu Y; Ye Y; Li Y; Qin P; Song P
Comput Math Methods Med; 2022; 2022():8090529. PubMed ID: 35529273
[TBL] [Abstract] [Full Text] [Related]
17. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract] [Full Text] [Related]
18. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract] [Full Text] [Related]
19. Fully automated detection of prostate transition zone tumors on T2-weighted and apparent diffusion coefficient (ADC) map MR images using U-Net ensemble.
Wong T; Schieda N; Sathiadoss P; Haroon M; Abreu-Gomez J; Ukwatta E
Med Phys; 2021 Nov; 48(11):6889-6900. PubMed ID: 34418108
[TBL] [Abstract] [Full Text] [Related]
20. Role of PSA Kinetics in Hormone-refractory prostate cancer.
Sabur V; Untan I; Tatlisen A
J Coll Physicians Surg Pak; 2021 Jun; 31(6):673-678. PubMed ID: 34102779
[TBL] [Abstract] [Full Text] [Related]
[Next]
